Opioid

Overview

As the opioid crisis continues to grow and claims more than 130 lives every day in the United States, Hall Booth Smith created the Opioid Strategic Team to defend physicians, surgeons, pain management specialists, and other health care providers as well as physician groups, hospitals, surgical centers, urgent care clinics, and other organizations on the full range of opioid and prescription-related claims they may face.

Health care providers face numerous threats and challenges such as civil lawsuits, malpractice claims, internal investigations, disciplinary actions, as well as Drug Enforcement Agency (DEA) audits and search warrants, investigations by the Federal Bureau of Investigation (FBI), and other government enforcement actions.

Opioid, prescription abuse, and health care fraud cases require specific knowledge and experience, such as a deep understanding of underlying health care laws and regulations, pending cases before other courts, precedent-setting verdicts and judgments, and appellate capabilities.

HBS’s Opioid Strategic Team includes senior partners, experienced associates, legal nurses, and expert witnesses who have worked together to defend clients in numerous cases across the Southeastern United States and beyond.

Our approach in critically assessing the facts of the case and evaluating risk exposure help us create negotiation and courtroom strategies that ensure a strong defense that protects each client’s rights and best interests.

The HBS Opioid Strategic Team also counsels clients on establishing best practices and oversight for prescription policies at practices, hospitals, surgical centers, and other health care facilities to ensure compliance with the Controlled Substance Act and minimize risk. We also work with clients to conduct internal investigations when issues arise and guide them through the best strategy for effectively and efficiently resolving those matters.